Pfizer (PFE) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Nebius Group is in a solid financial standing, at least for the remainder of 2025. Click here to see why NBIS stock is a Buy.